Table 4

p16 expression in endocervical and endometrial adenocarcinomas.

ECA

EMMA

p-value


0

2

5

1–10

1

1

11–50

1

8

Total score (0–50)

4/14 (29%)

14/18 (78%)

51–80

3

3

81–100

7

1

Total score (51–100)

10/14 (71%)

4/18 (22%)

0.005

Median (Range)

85 (0–100)

30 (0–100)

0.007


ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma.

Khoury et al. BMC Clinical Pathology 2006 6:1   doi:10.1186/1472-6890-6-1

Open Data